Junshi Biosciences Announces 2022 Full Year Financial Result

SHANGHAI, China, March 31, 2023 -- Shanghai Junshi Biosciences Co., Ltd , a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of... | March 31, 2023

Related Keywords

Morocco , Lingang , Jiangxi , China , Beijing , United Arab Emirates , Canada , Egypt , Suzhou , Jiangsu , Guangzhou , Guangdong , Jordan , Maryland , United States , Uzbekistan , Wujiang , Qatar , Saudi Arabia , Shanghai , San Francisco , California , Chinese , Kingdom Of Saudi Arabia , Zhi Li , Acta Pharmacologica Sinica , Junshi Biosciences , Junshi Bioscience , Shanghai Junshi Biosciences Co Ltd , Coherus Biosciences Inc , Pr Team , Sun Yat Sen University Cancer Center , Wigen Biomedicine Technology Shanghai Co Ltd , National Medical Products Administration Of China , Drug Administration , Market Of The Shanghai Stock Exchange On , European Medicines Agency , Risen Suzhou Biosciences Co Ltd , Ir Team , Shanghai Lingang Production , Shanghai Stock Exchange , National Medical Products Administration , United States Food , Signal Transduction , Targeted Therapy , New England Journal , Coherus Biosciences , Wigen Biomedicine Technology , Wigen Biomedicine , Immune Checkpoint , North Africa , Shanghai Lingang Production Base , Shanghai Junshi Biotech , Chinese Academy , Emergency Use Authorizations , Shanghai Junshi Biosciences Co , Td Stock Exchange , News , Information , Press Release , Arch , 023 , Junshi , Iosciences , Td , Reading , Iopharmaceutical , Company , Edicated , O , The , End , Ommercialization 1877 Cne100003ff7 ,